Evidence map›Paper›PMID 38458753›Full record

ArticleJournal of medical genetics2024

Cerebral visual impairment: genetic diagnoses and phenotypic associations.

Emogene Shaw, Ian Flitcroft, Richard Bowman, Kate Baker, Genomics England Research Consortium

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. The neurodevelopmental spectrum of CASK-related disorder.Journal of neurodevelopmental disorders · 2025
    Pooled it
  2. Visual function and autism spectrum disorder.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Article
  4. "My child can't see"-workup and management of children with low vision: a joint workshop of the AAPOS Low Vision Rehabilitation and Genetic Eye Diseases Committees.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Emogene ShawMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Ian FlitcroftChildren's University Hospital, Temple Street, Dublin, Ireland.
Richard BowmanGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Kate BakerMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK kb488@cam.ac.uk.ORCID 0000-0003-2986-0584
Genomics England Research Consortium
MRC Cognition and Brain Sciences Unit · GBGreat Ormond Street Hospital · GBTrinity College Dublin · IE

Funding

Wellcome TrustWellcome Trust WT223718/Z/21/Z
6 · The paper itself

Abstract

backgroundCerebral visual impairment (CVI) is the most common form of paediatric visual impairment in developed countries. CVI can arise from a host of genetic or acquired causes, but there has been limited research to date on CVI in the context of genetic disorders.

methodsWe carried out a retrospective analysis of genotypic and phenotypic data for participants with CVI within the DECIPHER database and 100 000 Genomes Project (100KGP).

results158 individuals with CVI were identified across both cohorts. Within this group, pathogenic or likely pathogenic sequence variants in 173 genes were identified. 25 of these genes already have known associations with CVI, while the remaining 148 are candidate genes for this phenotype. Gene ontology analysis of the CVI gene sets from both DECIPHER and 100KGP suggests that CVI has a similar degree of genetic heterogeneity to other neurodevelopmental phenotypes, and a strong association with genetic variants converging on ion channels and receptor functions. Individuals with a monogenic disorder and CVI have a higher frequency of epilepsies and severe neurodisability than individuals with a monogenic disorder but not CVI.

conclusionThis study supports the availability of genetic testing for individuals with CVI alongside other neurodevelopmental difficulties. It also supports the availability of ophthalmological screening for individuals with genetic diagnoses linked to CVI. Further studies could elaborate on the links between specific genetic disorders, visual maturation and broader neurodevelopmental characteristics.

Indexed as

PhenotypeAdolescentBlindness, CorticalChildChild, PreschoolDatabases, GeneticFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenetic TestingGenotypeHumansMaleRetrospective StudiesVision DisordersEpilepsyGeneticsGenomicsOphthalmology

Identifiers

PMID38458753
PMCPMC11137471
OpenAlexW4392583402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.